These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2638419)

  • 41. Effects of immunosuppressive therapy in biopsy-proved myocarditis and borderline myocarditis on left ventricular function.
    Jones SR; Herskowitz A; Hutchins GM; Baughman KL
    Am J Cardiol; 1991 Aug; 68(4):370-6. PubMed ID: 1858678
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term outcome of patients with virus-negative chronic myocarditis or inflammatory cardiomyopathy after immunosuppressive therapy.
    Escher F; Kühl U; Lassner D; Poller W; Westermann D; Pieske B; Tschöpe C; Schultheiss HP
    Clin Res Cardiol; 2016 Dec; 105(12):1011-1020. PubMed ID: 27312326
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression.
    Pieroni M; De Santis M; Zizzo G; Bosello S; Smaldone C; Campioni M; De Luca G; Laria A; Meduri A; Bellocci F; Bonomo L; Crea F; Ferraccioli G
    Semin Arthritis Rheum; 2014 Feb; 43(4):526-35. PubMed ID: 23932313
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Giant cell myocarditis responding to immunosuppressive therapy.
    Frustaci A; Chimenti C; Pieroni M; Gentiloni N
    Chest; 2000 Mar; 117(3):905-7. PubMed ID: 10713027
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prompt benefit of early immunosuppressive therapy in acute lymphocytic myocarditis with persistent heart failure.
    Weitsman T; Weisz G; Keren A; Hasin T
    Clin Res Cardiol; 2016 Sep; 105(9):794-6. PubMed ID: 27091051
    [No Abstract]   [Full Text] [Related]  

  • 46. [Immunosuppressive drugs for the treatment of active myocarditis in children. Hemodynamic evaluation].
    Camargo PR; Mazzieri R; Snitcowsky R; Ratti M; Costa R; Higuchi ML; Albuquerque AM; Meneghetti C; Ebaid M; Pileggi F
    Arq Bras Cardiol; 1990 Nov; 55(5):295-9. PubMed ID: 2090072
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunosuppressive therapy of chronic myocarditis in children: three cases and the design of a randomized prospective trial of therapy.
    Schmaltz AA; Demel KP; Kallenberg R; Neudorf U; Kandolf R; Klingel K; Bültmann B
    Pediatr Cardiol; 1998; 19(3):235-9. PubMed ID: 9568220
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relation between histological findings on early repeat right ventricular biopsy and ventricular function in patients with myocarditis.
    Dec GW; Fallon JT; Southern JF; Palacios IF
    Br Heart J; 1988 Oct; 60(4):332-7. PubMed ID: 3190962
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combined immunosuppression for the treatment of idiopathic giant cell myocarditis.
    Menghini VV; Savcenko V; Olson LJ; Tazelaar HD; Dec GW; Kao A; Cooper LT
    Mayo Clin Proc; 1999 Dec; 74(12):1221-6. PubMed ID: 10593350
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunosuppressive therapy in the management of acute myocarditis in children: a clinical trial.
    Chan KY; Iwahara M; Benson LN; Wilson GJ; Freedom RM
    J Am Coll Cardiol; 1991 Feb; 17(2):458-60. PubMed ID: 1991904
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Management of a patient with eosinophilic myocarditis and normal peripheral eosinophil count: case report and literature review.
    Fozing T; Zouri N; Tost A; Breit R; Seeck G; Koch C; Oezbek C
    Circ Heart Fail; 2014 Jul; 7(4):692-4. PubMed ID: 25028351
    [No Abstract]   [Full Text] [Related]  

  • 52. Lymphocytic myocarditis and dilated cardiomyopathy: treatment with immunosuppressive agents.
    Hobbs RE; Pelegrin D; Ratliff NB; Bott-Silverman C; Rincon G; Sterba R; Badhwar K
    Cleve Clin J Med; 1989 Sep; 56(6):628-35. PubMed ID: 2805327
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Myocarditis Treatment Trial: design, methods and patients enrollment.
    Hahn EA; Hartz VL; Moon TE; O'Connell JB; Herskowitz A; McManus BM; Mason JW
    Eur Heart J; 1995 Dec; 16 Suppl O():162-7. PubMed ID: 8682088
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Implications of the Myocarditis Treatment Trial for clinical practice.
    Brown CA; O'Connell JB
    Curr Opin Cardiol; 1996 May; 11(3):332-6. PubMed ID: 8835876
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunosuppressive therapy in virus-negative inflammatory cardiomyopathy: 20-year follow-up of the TIMIC trial.
    Chimenti C; Russo MA; Frustaci A
    Eur Heart J; 2022 Sep; 43(36):3463-3473. PubMed ID: 35831932
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Successful intravenous immunoglobulin therapy in a case of acute fulminant myocarditis.
    Ozyiğit T; Unal Z; Ozben B
    Turk Kardiyol Dern Ars; 2011 Jan; 39(1):59-63. PubMed ID: 21358234
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunosuppressive therapy in inflammatory myocarditis: long-term follow-up.
    Talwar KK; Goswami KC; Chopra P; Dev V; Shrivastava S; Malhotra A
    Int J Cardiol; 1992 Feb; 34(2):157-66. PubMed ID: 1737666
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunosuppressive therapy in myocarditis.
    Frustaci A; Chimenti C
    Circ J; 2015; 79(1):4-7. PubMed ID: 25452202
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Response of recurrent giant cell myocarditis in a transplanted heart to intensive immunosuppression.
    Kong G; Madden B; Spyrou N; Pomerance A; Mitchell A; Yacoub M
    Eur Heart J; 1991 Apr; 12(4):554-7. PubMed ID: 2065690
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunosuppressive therapy for myocarditis.
    Cunnion RE; Parrillo JE
    N Engl J Med; 1995 Dec; 333(25):1713; author reply 1714. PubMed ID: 7477235
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.